Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir.

McPhee, Fiona

Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir. [electronic resource] - Hepatology (Baltimore, Md.) Sep 2013 - 902-11 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1527-3350

10.1002/hep.26388 doi


Adult
Antiviral Agents--therapeutic use
Carbamates
Dose-Response Relationship, Drug
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Female
Genotype
Hepacivirus--genetics
Hepatitis C, Chronic--drug therapy
Humans
Imidazoles--therapeutic use
Interferon-alpha--therapeutic use
Interferons
Interleukins--genetics
Isoquinolines--therapeutic use
Male
Middle Aged
Polyethylene Glycols--therapeutic use
Pyrrolidines
RNA, Viral--genetics
Recombinant Proteins--therapeutic use
Ribavirin--therapeutic use
Sulfonamides--therapeutic use
Treatment Failure
Treatment Outcome
Valine--analogs & derivatives
Viral Nonstructural Proteins--genetics